Stock listing

CVM Stock Price, News, Filings & Events — Cel-sci Corporation

Selected listing: CVM · AMEX · USD · US

This page tracks Cel-sci Corporation's CVM:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CVM:AMEX. CVM:AMEX is the stock-level entry point for investors researching Cel-sci Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cel-sci Corporation, traded under the ticker CVM, is a public company based in America with a market capitalization of approximately $20.6 million. The company is focused on developing innovative therapies for cancer and other diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

CVM:AMEXUSDUSUpdated September 12, 2026
Cel-sci Corporation logo
Ticker
CVM:AMEX
Asset type
Stock
Market cap
$26.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
AMEX
Currency
USD

Cel-sci Corporation CVM:AMEX stock context

This page tracks Cel-sci Corporation's CVM:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CVM:AMEX. CVM:AMEX is the stock-level entry point for investors researching Cel-sci Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cel-sci Corporation, traded under the ticker CVM, is a public company based in America with a market capitalization of approximately $20.6 million. The company is focused on developing innovative therapies for cancer and other diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

Latest news from Cel-sci Corporation

All Cel-sci Corporation news →

Research Cel-sci Corporation

Alternate listings